BiotechTube
Home/NanoViricides/Ms. Meeta Vyas
MM

Ms. Meeta Vyas

Chief Financial Officer

NanoViricides

Therapeutic Areas

Infectious DiseaseVirologyDermatologyOphthalmology

NanoViricides Pipeline

DrugIndicationPhase
NV-387MPox / SmallpoxPhase 2
NV-HHV-1 (HerpeCide)Shingles (VZV) - Topical CreamPreclinical
HerpeCide ProgramHSV-1 (Cold Sores)Preclinical
HIVCideHIV (Potential Functional Cure)Preclinical
NanoViricidesDengue VirusPreclinical

Leadership Team at NanoViricides

DA
Dr. Anil R. Diwan
Executive Chairman, President
DR
Dr. Randall Barton
Chief Scientific Officer
MJ
Mr. Jayant Tatake
Vice President, R&D
DM
Dr. Mak Jawadekar
Independent Board Member
View full NanoViricides profile